IWC
ALNY icon

Integrated Wealth Concepts’s Alnylam Pharmaceuticals ALNY Stock Holding History

Integrated Wealth Concepts’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
4,467
-907
-17% -$274K 0.01% 1040
2026
Q1 		$1.78M Buy
5,374
+1,134
+27% +$386K 0.01% 806
2025
Q4 		$1.69M Sell
4,240
-396
-9% -$175K 0.02% 576
2025
Q3 		$2.11M Buy
4,636
+1,191
+35% +$485K 0.02% 651
2025
Q2 		$1.12M Buy
3,445
+706
+26% +$195K 0.01% 862
2025
Q1 		$740K Buy
2,739
+227
+9% +$58.3K 0.01% 966
2024
Q4 		$591K Buy
2,512
+176
+8% +$46.3K 0.01% 1051
2024
Q3 		$642K Buy
2,336
+22
+1% +$5.73K 0.01% 980
2024
Q2 		$562K Sell
2,314
-6
-0.3% -$947 0.01% 998
2024
Q1 		$347K Buy
2,320
+31
+1% +$5.17K 0.01% 1239
2023
Q4 		$438K Buy
2,289
+15
+0.7% +$2.56K 0.01% 1056
2023
Q3 		$403K Buy
2,274
+3
+0.1% +$572 0.01% 1073
2023
Q2 		$431K Sell
2,271
-135
-6% -$26.8K 0.01% 1053
2023
Q1 		$482K Buy
+2,406
New +$506K 0.01% 864

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Wealth Concepts's ALNY Position: Q2 2026 in Review

Integrated Wealth Concepts reduced its Alnylam Pharmaceuticals (ALNY) stake by 17% in Q2 2026, selling an estimated $274K and leaving 4,467 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #1040.

Integrated Wealth Concepts first reported a position in ALNY in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.11M in Q3 2025. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Integrated Wealth Concepts held 4,467 shares of Alnylam Pharmaceuticals worth $1.34M as of Q2 2026.
  • Integrated Wealth Concepts sold 907 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $274K.
  • Alnylam Pharmaceuticals made up 0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #1040 holding.
  • Integrated Wealth Concepts first reported a position in Alnylam Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Integrated Wealth Concepts's Alnylam Pharmaceuticals position peaked at $2.11M in Q3 2025.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.